FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4254347832> ?p ?o ?g. }

• W4254347832 abstract "Background Individuals with chronic bronchitis or chronic obstructive pulmonary disease (COPD) may suffer recurrent exacerbations with an increase in volume and/or purulence of sputum. Because of the personal and healthcare costs associated with exacerbations, any therapy that reduces the number of exacerbations is useful. There is a marked difference between countries in terms of prescribing of mucolytics depending on whether or not they are perceived to be effective. Objectives To assess the effects of oral mucolytics in adults with stable chronic bronchitis or COPD. Search methods We have searched the Cochrane Airways Group Specialised Register and reference lists of articles on four separate occasions, the most recent being in June 2007. Selection criteria Randomised trials that compared oral mucolytic therapy with placebo for at least two months in adults with chronic bronchitis or COPD. Studies of people with asthma and cystic fibrosis were excluded. Data collection and analysis One review author extracted data. Study authors and drug companies were contacted for missing information. Main results Twenty six trials involving 7335 participants were included. Compared with placebo, there was a significant reduction in the number of exacerbations per patient with oral mucolytics (weighted mean difference (WMD) ‐0.05 per month, 95% confidence interval ‐0.05 to ‐0.04). Using the annualised rate of exacerbations in the control patients of 2.6 per year, this is a 20% reduction. The number of days of disability also fell (WMD ‐0.56, 95% confidence interval ‐0.77 to ‐0.35). A recent study has shown that the benefit may apply only to those patients not already receiving inhaled corticosteroids. The number of patients who remained exacerbation‐free was greater in the mucolytic group (OR 2.13 (95% CI 1.86 to 2.42)). There was no difference in lung function or in adverse effects reported between the treatments. Authors' conclusions In participants with chronic bronchitis or COPD, treatment with mucolytics was associated with a small reduction in acute exacerbations and a reduction in total number of days of disability. Benefit may be greater in individuals who have frequent or prolonged exacerbations, or those who are repeatedly admitted to hospital with exacerbations with COPD. They should be considered for use, through the winter months at least, in patients with moderate or severe COPD in whom inhaled corticosteroids (ICS) are not prescribed." @default.
• W4254347832 created "2022-05-12" @default.
• W4254347832 creator A5004570305 @default.
• W4254347832 creator A5076546041 @default.
• W4254347832 date "2006-07-19" @default.
• W4254347832 modified "2023-10-04" @default.
• W4254347832 title "Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease" @default.
• W4254347832 cites W1576173198 @default.
• W4254347832 cites W1978444750 @default.
• W4254347832 cites W1983144275 @default.
• W4254347832 cites W1986215651 @default.
• W4254347832 cites W1998229291 @default.
• W4254347832 cites W2005380677 @default.
• W4254347832 cites W2007664092 @default.
• W4254347832 cites W2012284731 @default.
• W4254347832 cites W2013697207 @default.
• W4254347832 cites W2013980885 @default.
• W4254347832 cites W2017985444 @default.
• W4254347832 cites W2044025644 @default.
• W4254347832 cites W2045749557 @default.
• W4254347832 cites W2048571011 @default.
• W4254347832 cites W2050990313 @default.
• W4254347832 cites W2057759589 @default.
• W4254347832 cites W2063678958 @default.
• W4254347832 cites W2087013331 @default.
• W4254347832 cites W2127376513 @default.
• W4254347832 cites W2128702913 @default.
• W4254347832 cites W2133119676 @default.
• W4254347832 cites W2135682290 @default.
• W4254347832 cites W2154547937 @default.
• W4254347832 cites W2159829097 @default.
• W4254347832 cites W4214481755 @default.
• W4254347832 cites W4241797338 @default.
• W4254347832 doi "https://doi.org/10.1002/14651858.cd001287.pub2" @default.
• W4254347832 hasPublicationYear "2006" @default.
• W4254347832 type Work @default.
• W4254347832 citedByCount "26" @default.
• W4254347832 countsByYear W42543478322012 @default.
• W4254347832 countsByYear W42543478322013 @default.
• W4254347832 countsByYear W42543478322014 @default.
• W4254347832 countsByYear W42543478322015 @default.
• W4254347832 countsByYear W42543478322016 @default.
• W4254347832 countsByYear W42543478322017 @default.
• W4254347832 countsByYear W42543478322019 @default.
• W4254347832 countsByYear W42543478322021 @default.
• W4254347832 crossrefType "reference-entry" @default.
• W4254347832 hasAuthorship W4254347832A5004570305 @default.
• W4254347832 hasAuthorship W4254347832A5076546041 @default.
• W4254347832 hasConcept C126322002 @default.
• W4254347832 hasConcept C142724271 @default.
• W4254347832 hasConcept C177713679 @default.
• W4254347832 hasConcept C1862650 @default.
• W4254347832 hasConcept C204787440 @default.
• W4254347832 hasConcept C27081682 @default.
• W4254347832 hasConcept C2776042228 @default.
• W4254347832 hasConcept C2776301714 @default.
• W4254347832 hasConcept C2776780178 @default.
• W4254347832 hasConcept C2777014857 @default.
• W4254347832 hasConcept C2777714996 @default.
• W4254347832 hasConcept C2779379686 @default.
• W4254347832 hasConcept C2779993553 @default.
• W4254347832 hasConcept C2781069245 @default.
• W4254347832 hasConcept C2992694001 @default.
• W4254347832 hasConcept C44249647 @default.
• W4254347832 hasConcept C71924100 @default.
• W4254347832 hasConceptScore W4254347832C126322002 @default.
• W4254347832 hasConceptScore W4254347832C142724271 @default.
• W4254347832 hasConceptScore W4254347832C177713679 @default.
• W4254347832 hasConceptScore W4254347832C1862650 @default.
• W4254347832 hasConceptScore W4254347832C204787440 @default.
• W4254347832 hasConceptScore W4254347832C27081682 @default.
• W4254347832 hasConceptScore W4254347832C2776042228 @default.
• W4254347832 hasConceptScore W4254347832C2776301714 @default.
• W4254347832 hasConceptScore W4254347832C2776780178 @default.
• W4254347832 hasConceptScore W4254347832C2777014857 @default.
• W4254347832 hasConceptScore W4254347832C2777714996 @default.
• W4254347832 hasConceptScore W4254347832C2779379686 @default.
• W4254347832 hasConceptScore W4254347832C2779993553 @default.
• W4254347832 hasConceptScore W4254347832C2781069245 @default.
• W4254347832 hasConceptScore W4254347832C2992694001 @default.
• W4254347832 hasConceptScore W4254347832C44249647 @default.
• W4254347832 hasConceptScore W4254347832C71924100 @default.
• W4254347832 hasLocation W42543478321 @default.
• W4254347832 hasOpenAccess W4254347832 @default.
• W4254347832 hasPrimaryLocation W42543478321 @default.
• W4254347832 hasRelatedWork W2003982228 @default.
• W4254347832 hasRelatedWork W2059086374 @default.
• W4254347832 hasRelatedWork W2087573979 @default.
• W4254347832 hasRelatedWork W2096145926 @default.
• W4254347832 hasRelatedWork W2117645496 @default.
• W4254347832 hasRelatedWork W2222532451 @default.
• W4254347832 hasRelatedWork W2404968759 @default.
• W4254347832 hasRelatedWork W2416587185 @default.
• W4254347832 hasRelatedWork W2418115673 @default.
• W4254347832 hasRelatedWork W4226163558 @default.
• W4254347832 isParatext "false" @default.
• W4254347832 isRetracted "false" @default.
• W4254347832 workType "reference-entry" @default.